International nostalgia acts have always found success in Australia. For some, it’s a far-off second home that guarantees a ...

This week, Pfizer and French vaccine company, Valneva, released phase 3 clinical trial data for PF-0730740, a four-dose Lyme disease vaccine they developed together that is about 70% effective. While ...

A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed the results from a phase 3 trial. If approved by regulators, it would be the ...

Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.

Pfizer said it will seek regulatory approval for a Lyme disease vaccine candidate despite failing a late-stage trial. Pfizer said not enough people contracted Lyme disease to be confident in the ...

When the topic of Lyme disease comes up, Robert F. Kennedy Jr. often tells a story about standing in a bathtub in Westchester County, New York, in the 1980s, picking almost 30 ticks off of himself ...

Four doses of an experimental vaccine to protect against Lyme disease reduced the number of tick-borne infections by more than 70 percent, according to Pfizer and Valneva, the pharmaceutical companies ...

Pfizer has announced that its new Lyme disease vaccine reduced the rate of infection by more than 70 percent in a recent trial. This is a notable achievement as an estimated 476,000 Americans contract ...

Scientists found that the experimental vaccine was more than 70% effective at preventing Lyme disease in a trial of nearly 10,000 volunteers. Reading time 3 minutes Ticks and the many diseases they ...

The pharmaceutical companies testing out a new Lyme disease vaccine said Monday they plan to seek approvals from the federal government even though the latest clinical trial results were not as ...